Clinical trials for cellular, acellular and matrix-like products (CAMPs): an evidence consensus

Serena, T.E. (Chair), Andersen, C., Bohn, G., Cosentino, G., Davis, M., Desvigne, M., Kaur, A., Low, M., Oropallo, A., Roselli, L., Sabatino, C., Simman, R., Slade, B., Tunyiswa, Z., & Wahab, N.

International Journal of Tissue Repair (IJTR)

No abstract is published for this item. Use the full text link for the complete document.

Keywords

CAMPscellular acellular and matrix-like productsCenters for Medicare and Medicaid Servicesclinical trialswound healingevidence consensus

Related in CAMP Studies and Therapeutics

Cellular, acellular, and matrix-like products (CAMPs) for soft-tissue reconstruction in acute surgical and traumatic wounds
Suggested minimal evidence for CAMP coverage
Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers